| Zolinza Treats Rare Skin Cancer (HealthDay) - in yahoo news - HealthDay - FRIDAY, Oct. 6 (HealthDay News) -- Zolinza has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell lymphoma (CTCL), a rare form of skin cancer, the agency said Friday. |